Copyright Reports & Markets. All rights reserved.

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Product
      • 1.4.2 Aloxi (palonosetron)
      • 1.4.3 Kytril Generic (granisetron)
      • 1.4.4 Emend (aprepitant)
      • 1.4.5 Akynzeo (netupitant-palonosetron)
    • 1.5 Market by End User
      • 1.5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by End User
      • 1.5.2 Blood Cancer
      • 1.5.3 Breast Cancer
      • 1.5.4 Gastrointestinal Tract Cancer
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size
      • 2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2014-2025
      • 2.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2014-2025
    • 2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Growth Rate by Regions
      • 2.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Regions
      • 2.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers
      • 3.1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers
      • 3.1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers
      • 3.2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Manufacturers
    • 3.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Product
    • 4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Product
    • 4.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Countries
      • 6.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries
      • 6.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Product
    • 6.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by End User

    7 Europe

    • 7.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Countries
      • 7.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries
      • 7.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Product
    • 7.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Countries
      • 8.1.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries
      • 8.1.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Product
    • 8.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Countries
      • 9.1.1 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries
      • 9.1.2 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Product
    • 9.3 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Countries
      • 10.1.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Product
    • 10.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by End User

    11 Company Profiles

    • 11.1 GlaxoSmithKline
      • 11.1.1 GlaxoSmithKline Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GlaxoSmithKline Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.1.5 GlaxoSmithKline Recent Development
    • 11.2 Helsinn
      • 11.2.1 Helsinn Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.2.5 Helsinn Recent Development
    • 11.3 Heron Therapeutics
      • 11.3.1 Heron Therapeutics Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.3.5 Heron Therapeutics Recent Development
    • 11.4 Merck & Co
      • 11.4.1 Merck & Co Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck & Co Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.4.5 Merck & Co Recent Development
    • 11.5 Tesaro
      • 11.5.1 Tesaro Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Tesaro Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.5.5 Tesaro Recent Development
    • 11.6 Acacia Pharma
      • 11.6.1 Acacia Pharma Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Acacia Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.6.5 Acacia Pharma Recent Development
    • 11.7 Aphios
      • 11.7.1 Aphios Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Aphios Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.7.5 Aphios Recent Development
    • 11.8 Barr Laboratories
      • 11.8.1 Barr Laboratories Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Barr Laboratories Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.8.5 Barr Laboratories Recent Development
    • 11.9 Baxter Healthcare
      • 11.9.1 Baxter Healthcare Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Baxter Healthcare Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.9.5 Baxter Healthcare Recent Development
    • 11.10 Eisai
      • 11.10.1 Eisai Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
      • 11.10.5 Eisai Recent Development
    • 11.11 Especificos Stendhal
    • 11.12 F.Hoffmann La Roche
    • 11.13 Mundipharma
    • 11.14 Mylan Pharmaceuticals
    • 11.15 OPKO Health
    • 11.16 Orchid Healthcare

    12 Future Forecast

    • 12.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Regions
      • 12.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Product
      • 12.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by End User
    • 12.4 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast
    • 12.5 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast
    • 12.6 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast
    • 12.7 Central & South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast
    • 12.8 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy.
      North America is the largest sales region of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
      The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in these regions.
      This research report categorizes the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market by top players/brands, region, type and end user. This report also studies the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GlaxoSmithKline
      Helsinn
      Heron Therapeutics
      Merck & Co
      Tesaro
      Acacia Pharma
      Aphios
      Barr Laboratories
      Baxter Healthcare
      Eisai
      Especificos Stendhal
      F.Hoffmann La Roche
      Mundipharma
      Mylan Pharmaceuticals
      OPKO Health
      Orchid Healthcare

      Market size by Product
      Aloxi (palonosetron)
      Kytril Generic (granisetron)
      Emend (aprepitant)
      Akynzeo (netupitant-palonosetron)
      Market size by End User
      Blood Cancer
      Breast Cancer
      Gastrointestinal Tract Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now